WOK
WORK Medical·NASDAQ
--
--(--)
--
--(--)
1.28 / 10
Underperform
WORK Medical's financial analysis is challenging, scoring only 1.3/10. Key profitability metrics like ROA (-0.0829) and net profit margin on assets (-0.1658) are negative, while the net cash flow to revenue ratio is a significant -61.56%. Although the net profit to total profit ratio (24.28%) offers some optimism, it is insufficient to offset other weaknesses, leading to a prudent stance.
Analysis Checks(2/4)
ROA (%)
Value-0.08
Score2/3
Weight5.50%
1M Return-0.25%
Value-0.08
Score2/3
Weight5.50%
1M Return-0.25%
Annualized net profit margin on total assets (%)
Value-0.17
Score2/3
Weight5.50%
1M Return-0.25%
Value-0.17
Score2/3
Weight5.50%
1M Return-0.25%
Net cash flow from operating activities / Operating revenue (%)
Value-61.56
Score1/3
Weight45.67%
1M Return-2.56%
Value-61.56
Score1/3
Weight45.67%
1M Return-2.56%
Net profit / Total profit (%)
Value24.28
Score1/3
Weight43.33%
1M Return-2.49%
Value24.28
Score1/3
Weight43.33%
1M Return-2.49%
ROA (%)
Value-0.08
Score2/3
Weight5.50%
1M Return-0.25%
Value-0.08
Score2/3
Weight5.50%
1M Return-0.25%
Net cash flow from operating activities / Operating revenue (%)
Value-61.56
Score1/3
Weight45.67%
1M Return-2.56%
Value-61.56
Score1/3
Weight45.67%
1M Return-2.56%
Annualized net profit margin on total assets (%)
Value-0.17
Score2/3
Weight5.50%
1M Return-0.25%
Value-0.17
Score2/3
Weight5.50%
1M Return-0.25%
Net profit / Total profit (%)
Value24.28
Score1/3
Weight43.33%
1M Return-2.49%
Value24.28
Score1/3
Weight43.33%
1M Return-2.49%
Is WOK fundamentally strong?
- WOK scores 1.28/10 on fundamentals and holds a Premium valuation at present. Backed by its -5.76% ROE, -12.19% net margin, -2.22 P/E ratio, 0.11 P/B ratio, and 85.19% earnings growth, these metrics solidify its Underperform investment rating.
